93 related articles for article (PubMed ID: 3201105)
1. Reduced angiotensin II induced vascular reactivity in chronic renal failure.
Jespersen B; Pedersen EB; Christensen NJ; Danielsen H; Sørensen SS
Scand J Clin Lab Invest; 1988 Nov; 48(7):705-13. PubMed ID: 3201105
[TBL] [Abstract][Full Text] [Related]
2. Hypotension in end-stage renal disease: effect of postural change, exercise and angiotensin II infusion on blood pressure and plasma concentrations of angiotensin II, aldosterone and arginine vasopressin in hypotensive patients with chronic renal failure treated by dialysis.
Sørensen SS; Danielsen H; Jespersen B; Pedersen EB
Clin Nephrol; 1986 Dec; 26(6):288-96. PubMed ID: 3802595
[TBL] [Abstract][Full Text] [Related]
3. Increased plasma levels of atrial natriuretic peptide in patients with chronic renal failure: effect of noradrenaline infusion.
Jespersen B; Pedersen EB
Nephrol Dial Transplant; 1988; 3(6):762-7. PubMed ID: 2976128
[TBL] [Abstract][Full Text] [Related]
4. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
Elsharkawy MM; Youssef AM; Zayoon MY
Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
[TBL] [Abstract][Full Text] [Related]
5. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
6. Response of vasoactive substances to reduction of blood volume during hemodialysis in hypotensive patients.
Heintz B; Reiners K; Gladziwa U; Kirsten R; Nelson K; Wieland D; Riehl J; Mann H; Sieberth HG
Clin Nephrol; 1993 Apr; 39(4):198-204. PubMed ID: 8491049
[TBL] [Abstract][Full Text] [Related]
7. Vasoactive hormones in children with chronic renal failure.
Rauh W; Hund E; Sohl G; Rascher W; Mehls O; Schärer K
Kidney Int Suppl; 1983 Nov; 15():S27-33. PubMed ID: 6368949
[TBL] [Abstract][Full Text] [Related]
8. Adenosine-angiotensin II interactions. Part II. The role of adenosine in regulating angiotensin II-induced changes in heart rate and aldosterone release.
Holycross BJ; Li P; Jackson EK
J Pharmacol Exp Ther; 1989 Aug; 250(2):442-53. PubMed ID: 2760838
[TBL] [Abstract][Full Text] [Related]
9. Abnormal distal tubular sodium reabsorption during dopamine infusion in patients with essential hypertension evaluated by the lithium clearance methods.
Nielsen CB; Pedersen EB
Clin Nephrol; 1997 May; 47(5):304-9. PubMed ID: 9181277
[TBL] [Abstract][Full Text] [Related]
10. Relationship between serum parathyroid hormone and trace elements (serum zinc and magnesium) in hemodialyzed chronic renal failure children.
El Tayeb AA; Abd El-Mottaleb NA; Abdel Aziz EA
Biol Trace Elem Res; 2009 May; 128(2):128-34. PubMed ID: 18972069
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of endotoxaemia on pressor and vasoconstrictor actions of angiotensin II and arginine vasopressin in conscious rats.
Tarpey SB; Bennett T; Randall MD; Gardiner SM
Br J Pharmacol; 1998 Apr; 123(7):1367-74. PubMed ID: 9579732
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II, aldosterone and arginine vasopressin in plasma in congestive heart failure.
Pedersen EB; Danielsen H; Jensen T; Madsen M; Sørensen SS; Thomsen OO
Eur J Clin Invest; 1986 Feb; 16(1):56-60. PubMed ID: 3084274
[TBL] [Abstract][Full Text] [Related]
13. Effect of sympathetic and plasma renin activity on hemodialysis hypertension.
Grekas D; Kalevrosoglou I; Karamouzis M; Geropoulou E; Kabouris H; Tourkantonis A
Clin Nephrol; 2001 Feb; 55(2):115-20. PubMed ID: 11269674
[TBL] [Abstract][Full Text] [Related]
14. Differing thresholds for modulatory effects of adrenomedullin infusion on haemodynamic and hormone responses to angiotensin II and adrenocorticotrophic hormone in healthy volunteers.
Troughton RW; Frampton CM; Lewis LK; Yandle TG; Richards AM; Nicholls MG
Clin Sci (Lond); 2001 Jul; 101(1):103-9. PubMed ID: 11410122
[TBL] [Abstract][Full Text] [Related]
15. Effects of acute mild hypercalcemia or of the calcium antagonist nifedipine on cardiovascular responsiveness to norepinephrine or angiotensin II in normal humans.
Beretta-Piccoli C; Bianchetti MG; Weidmann P; Boehringer K; Link L; Morton JJ
J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S306-12. PubMed ID: 6184559
[TBL] [Abstract][Full Text] [Related]
16. Effects of subpressor doses of angiotensin II on renal hemodynamics in relation to blood pressure.
Ljungman S; Aurell M; Hartford M; Wikstrand J; Berglund G
Hypertension; 1983; 5(3):368-74. PubMed ID: 6341220
[TBL] [Abstract][Full Text] [Related]
17. Neurohormonal activation in patients with acute myocardial infarction or chronic congestive heart failure. With special reference to treatment with angiotensin converting enzyme inhibitors.
Sigurdsson A
Blood Press Suppl; 1995; 1():1-45. PubMed ID: 7599749
[TBL] [Abstract][Full Text] [Related]
18. Exogenous insulin augments in healthy volunteers the cardiovascular reactivity to noradrenaline but not to angiotensin II.
Gans RO; Bilo HJ; von Maarschalkerweerd WW; Heine RJ; Nauta JJ; Donker AJ
J Clin Invest; 1991 Aug; 88(2):512-8. PubMed ID: 1864961
[TBL] [Abstract][Full Text] [Related]
19. Forearm vasoconstrictor response to ouabain: studies in patients with mild and moderate essential hypertension.
Hulthén UL; Bolli P; Kiowski W; Bühler FR
J Cardiovasc Pharmacol; 1984; 6 Suppl 1():S75-81. PubMed ID: 6204162
[TBL] [Abstract][Full Text] [Related]
20. Factors modulating cytosolic calcium. Role in lipid metabolism and cardiovascular morbidity and mortality in peritoneal dialysis patients.
Gadallah MF; el-Shahawy M; Andrews G; Ibrahim M; Ramdeen G; Hanna D; Gorospe W; Morkos A; Abbassian M; Moles K
Adv Perit Dial; 2001; 17():29-36. PubMed ID: 11510292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
